Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Greenwald

Showing results (191-200 of 229) with videos related to

Pageof 23
Sort By:
Plastic and Reconstructive Surgery|December 1, 1991
Skin closure with dye-enhanced laser welding and fibrinogenT M Wider, S K Libutti, D P Greenwald, et al.
Cancer|July 1, 1976
Morbidity and mortality among recipients of blood from preleukemic and prelymphomatous donorsP Greenwald, E Woodard, P C Nasca, et al.
Journal of Autism and Developmental Disorders|February 6, 2013
Brief report: is cognitive rehabilitation needed in verbal adults with autism? Insights from initial enrollment in a trial of cognitive enhancement therapyShaun M Eack, Amber L Bahorik, Susan S Hogarty, et al.
Journal of Autism and Developmental Disorders|April 27, 2013
Cognitive enhancement therapy for adults with autism spectrum disorder: results of an 18-month feasibility studyShaun M Eack, Deborah P Greenwald, Susan S Hogarty, et al.
Archives of General Psychiatry|July 1, 1986
Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. I. One-year effects of a controlled study on relapse and expressed emotionG E Hogarty, C M Anderson, D J Reiss, et al.
Psychiatric Services (Washington, D.C.)|November 3, 2009
Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trialShaun M Eack, Deborah P Greenwald, Susan S Hogarty, et al.
Autism Research : Official Journal of the International Society for Autism Research|December 30, 2017
Cognitive enhancement therapy for adult autism spectrum disorder: Results of an 18-month randomized clinical trialShaun M Eack, Susan S Hogarty, Deborah P Greenwald, et al.
Archives of General Psychiatry|May 5, 2010
Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trialShaun M Eack, Gerard E Hogarty, Raymond Y Cho, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2000
Perspectives on surrogate end points in the development of drugs that reduce the risk of cancerG J Kelloff, C C Sigman, K M Johnson, et al.
Journal of the National Cancer Institute|January 5, 1994
Dietary beta carotene and lung cancer risk in U.S. nonsmokersS T Mayne, D T Janerich, P Greenwald, et al.
Pageof 23

Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
Plastic and Reconstructive Surgery|December 1, 1991
Skin closure with dye-enhanced laser welding and fibrinogenT M Wider, S K Libutti, D P Greenwald, et al.
Cancer|July 1, 1976
Morbidity and mortality among recipients of blood from preleukemic and prelymphomatous donorsP Greenwald, E Woodard, P C Nasca, et al.
Journal of Autism and Developmental Disorders|February 6, 2013
Brief report: is cognitive rehabilitation needed in verbal adults with autism? Insights from initial enrollment in a trial of cognitive enhancement therapyShaun M Eack, Amber L Bahorik, Susan S Hogarty, et al.
Journal of Autism and Developmental Disorders|April 27, 2013
Cognitive enhancement therapy for adults with autism spectrum disorder: results of an 18-month feasibility studyShaun M Eack, Deborah P Greenwald, Susan S Hogarty, et al.
Archives of General Psychiatry|July 1, 1986
Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. I. One-year effects of a controlled study on relapse and expressed emotionG E Hogarty, C M Anderson, D J Reiss, et al.
Psychiatric Services (Washington, D.C.)|November 3, 2009
Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trialShaun M Eack, Deborah P Greenwald, Susan S Hogarty, et al.
Autism Research : Official Journal of the International Society for Autism Research|December 30, 2017
Cognitive enhancement therapy for adult autism spectrum disorder: Results of an 18-month randomized clinical trialShaun M Eack, Susan S Hogarty, Deborah P Greenwald, et al.
Archives of General Psychiatry|May 5, 2010
Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trialShaun M Eack, Gerard E Hogarty, Raymond Y Cho, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2000
Perspectives on surrogate end points in the development of drugs that reduce the risk of cancerG J Kelloff, C C Sigman, K M Johnson, et al.
Journal of the National Cancer Institute|January 5, 1994
Dietary beta carotene and lung cancer risk in U.S. nonsmokersS T Mayne, D T Janerich, P Greenwald, et al.
Pageof 23